Trials / Completed
CompletedNCT03461224
Modulated Accelerated RAdiotherapy in Early Breast Cancer
Postoperative Modulated Accelerated RAdiotherapy (MARA-1) for Early Stage Breast Cancer: a Retrospective Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 447 (actual)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This trial was a retrospective study on postoperative accelerated hypofractionated IMRT (MARA-1) in patients with early stage breast carcinoma, to compare late toxicity after this treatment and standard fractionated RT delivered with 3D-CRT.
Detailed description
The aim of this study was to evaluate the clinical results in terms of late skin and subcutaneous toxicity of accelerated hypofractionated forward-planned IMRT in patients with early stage BC. Results were compared with a historical control group (CG) of patients treated with 3D-conformal postoperative RT delivered with conventional fractionation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | accelerated hypofractionated RT | |
| RADIATION | conventional fractionated RT |
Timeline
- Start date
- 2001-01-10
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2018-03-09
- Last updated
- 2018-03-12
Source: ClinicalTrials.gov record NCT03461224. Inclusion in this directory is not an endorsement.